Hint mode is switched on Switch off
For swift navigation between sections

Advanz Pharma
LEI 549300WZSXRSISJ4VI31

PDF download

Choose all Reset all
Download Cancel
The issuer's bonds defaulted in 2017
Organization name
Advanz Pharma Corp. (formerly Concordia International Corp.)
Country name
Canada
Country of registration
Canada
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Advanz Pharma Corp. (formerly Concordia International Corp.) operates a healthcare business that includes the management and acquisition of legacy pharmaceutical products and acquires and develops orphan drugs both with patent life and exclusivity remaining (pre-legacy), and products that have reached full maturity but continue on a predictable revenue generation path, collectively referred to as legacy products.

Awards

News

07/10/2016 New bond issue: Concordia Healthcare issued international bonds for USD 350.0m maturing in 2022 with a 9% coupon.
20/10/2015 New bond issue: Concordia Healthcare sells USD 790.0m in 2022 bonds with a 9.5% coupon
14/04/2015 New bond issue: Concordia Healthcare sells USD 735.0m in 2023 bonds with a 7% coupon
All organization news

Documentation

IFRS/US GAAP reports

2017
IV q eng
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300WZSXRSISJ4VI31
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001642271
Registration is required to get access.